s 9788 and Neoplasms
s 9788 has been researched along with Neoplasms in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Berlion, M; Bizzari, JP; Calvo, F; Haddad, P; Lucas, C; Soudon, J | 1 |
| de Vries, EG; Hill, BT; Hosking, LK; Mulder, NH; van der Graaf, WT; Whelan, RD | 1 |
| Anstett, M; Atassi, G; Léonce, S; Pérez, V; Pierré, A; Prost, JF | 1 |
| Ardiet, C; Barbet, N; Bastian, G; Catimel, G; Clavel, M; Dumortier, A; Evene, E; Foy, M; Froudarakis, M; Grossin, F; Guastalla, JP; Lucas, C; Mazier, B; Négrier, S; Rebattu, P; Sarkany, M; Tranchand, B | 1 |
Trials
2 trial(s) available for s 9788 and Neoplasms
| Article | Year |
|---|---|
In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients.
Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Division; Cell Line; Cell Survival; Culture Media; Doxorubicin; Drug Resistance, Multiple; Drug Synergism; Hematopoietic Stem Cells; Humans; Leukemia, T-Cell; Neoplasms; Phenotype; Piperidines; Reference Values; Triazines; Tumor Cells, Cultured; Verapamil; Vinblastine | 1995 |
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bradycardia; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Neoplasms; Piperidines; Triazines | 1998 |
Other Studies
2 other study(ies) available for s 9788 and Neoplasms
| Article | Year |
|---|---|
Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Membrane Glycoproteins; Molecular Structure; Neoplasms; Piperidines; Triazines; Tumor Cells, Cultured; Verapamil; Vinblastine; Vincristine | 1993 |
[In vitro characterization of S9788, a new modulator of multidrug resistance].
Topics: Animals; Antineoplastic Agents; Cell Cycle; Drug Resistance; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Mice; Neoplasms; Neoplasms, Experimental; Phenotype; Piperidines; Triazines; Tumor Cells, Cultured; Verapamil | 1993 |